Citations 3
Correction: Devices and techniques for bariatric and metabolic endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Technical and Technology Review
Boškoski, Ivo , Shamah, Steven, Bove, Vincenzo , Siena, Martina De , Huberty, Vincent , Perretta, Silvana , Sharaiha, Reem Z. , De Siena, Martina , Huberty, Vincent , Sharaiha, Reem Z , Facciorusso, Antonio , Fuccio, Lorenzo , Costamagna, Guido , Matteo, Maria Valeria , Dayyeh, Barham K. Abu , Maselli, Roberta , Pontecorvi, Valerio , Stier, Christine , Facciorusso, Antonio , Fuccio, Lorenzo
Endoscopy | November 7, 2025 | Volume: 57 | Issue: 11 | Pages: C19-C19
Devices and techniques for bariatric and metabolic endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Technical and Technology Review
Boškoski, Ivo , Shamah, Steven, Bove, Vincenzo , Siena, Martina De , Huberty, Vincent , Perretta, Silvana , Pontecorvi, Valerio , Stier, Christine , Sharaiha, Reem Z. , De Siena, Martina , Huberty, Vincent , Sharaiha, Reem Z , Facciorusso, Antonio , Fuccio, Lorenzo , Costamagna, Guido , Matteo, Maria Valeria , Dayyeh, Barham K. Abu , Maselli, Roberta , Facciorusso, Antonio , Fuccio, Lorenzo
Endoscopy | July 9, 2025 | Volume: 57 | Issue: 09 | Pages: 1033-1055
Abstract Endoscopic bariatric and metabolic therapies (EBMTs) are increasingly recognized as valuable tools for managing obesity and related metabolic disorders. As the prevalence of obesity continues to rise globally, there is a growing demand for effective, safe, and less invasive treatment options. This review provides a comprehensive summary of the available EBMTs, including both stomach-targeted and small-bowel-targeted devices. The review details the various devices, outlines the techniques for their proper use, and discusses their indications. It also presents data on their efficacy and safety, and the management of adverse events and weight regain, as well as anticipated future developments. The paper emphasizes the necessity for additional high quality randomized controlled trials and long-term outcome data to better define the role of these therapies within obesity treatment protocols. Overall, this review serves as an authoritative resource for endoscopists, bariatric specialists, and the wider healthcare community involved in obesity care, promoting best practices and guiding the appropriate implementation of EBMTs in clinical settings.
American Society for Gastrointestinal Endoscopy–European Society of Gastrointestinal Endoscopy guideline on primary endoscopic bariatric and metabolic therapies for adults with obesity
Jirapinyo, Pichamol , Hadefi, Alia , Sullivan, Shelby , Thompson, Christopher C. , Patai, Árpád V. , Pannala, Rahul , Goelder, Stefan, Kushnir, Vladimir , Apovian, Caroline M., Chapman, Christopher G., Davidson, Paul , Kumbhari, Vivek , Esker, Janelle, Hucl, Tomáš , Schulman, Allison R. , Zelber‐Sagi, Shira , Bain, Paul , Huberty, Vincent , Barthet, Marc , Boškoski, Ivo , Donatelli, Gianfranco , Hayee, Bu , Pryor, Aurora Dawn , Maselli, Roberta , Pattou, François , Durieux, Valérie , Τriantafyllou, Κonstantinos , Thosani, Nirav C
Endoscopy | April 19, 2024 | Volume: 56 | Issue: 06 | Pages: 437-456
AbstractThis joint ASGE-ESGE guideline provides an evidence-based summary and recommendations regarding the role of endoscopic bariatric and metabolic therapies (EBMTs) in the management of obesity. The document was developed using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) framework. It evaluates the efficacy and safety of EBMT devices and procedures that currently have CE mark or FDA-clearance/approval, or that had been approved within five years of document development. The guideline suggests the use of EBMTs plus lifestyle modification in patients with a BMI of ≥30 kg/m2, or with a BMI of 27.0–29.9 kg/m2 with at least 1 obesity-related comorbidity. Furthermore, it suggests the utilization of intragastric balloons and devices for endoscopic gastric remodeling (EGR) in conjunction with lifestyle modification for this patient population.